+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

US Sexually Transmitted Diseases (STD) Diagnostics Market 2019-2025

  • ID: 5116799
  • Report
  • February 2020
  • Region: United States
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • AbbVie Inc.
  • Becton, Dickinson and Co.
  • Biocartis NV
  • Danaher Corp.
  • Eli Lilly and Co.
US Sexually Transmitted Diseases (STD) Diagnostics Market Size, Share & Trends Analysis Report by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV), Human Immunodeficiency Virus (HIV), and Others), by Product (Laboratory Testing Devices, and Point-of-Care (POC) Testing Devices) by End-user (Hospitals and Clinics, Diagnostic Centers, and Homecare) Forecast Period 2019-2025.

US STD diagnostics market is growing at a CAGR of around 8.1% during the forecast period. The major aspects that are making considerable contributing towards its high market share include the fact that the country emphasizes more towards increasing the efficiency with the effectiveness of the treatment of various diseases including STDs. Further, the rapidly developed healthcare infrastructure and significant government healthcare spending are promoting R&D of such advanced technology across the country thereby promoting the growth of the US STD diagnostics market.

According to the Research America, the US had spent $182.3 billion in R&D of medical and healthcare and several investments were made by the foundations, industries, Federal agencies and others. The federal agencies had invested more than $35.9 million along with National Institute of Health that comprises $29.6 billion share. There was several spending that the US healthcare and medical had received for research and development R&D activities.

Several research segments such as healthcare and medical researchers, federal government, academic and research institutes, non-research conducting grant giving entities, as well as state and local government in the US tend to invest heavily in the research of healthcare and medical drugs, medical devices which directly affects the growth of the US STD diagnostics market during the forecast period.

Abbott Laboratories, Inc., Becton, Dickinson and Co., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific, Inc. among others are some of the key players operating in the US STD diagnostics market. The STD diagnostics key players are adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others in order to thrive in a competitive environment.

Research Methodology:

The market study of the US STD Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. US STD Diagnostics Market Research and Analysis by Disease Type
2. US STD Diagnostics Market Research and Analysis by Product
3. US STD Diagnostics Market Research and Analysis by End-user

The Report Covers:
  • Comprehensive Research Methodology of the US STD Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the US STD Diagnostics market.
  • Insights about market determinants which are stimulating the US STD Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • AbbVie Inc.
  • Becton, Dickinson and Co.
  • Biocartis NV
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown